Research map: Fasting insulin to HDL-C ratio is correlated with MASLD severity in Chinese overweight/obesity: a cross-sectional analysis

Back to the article

Papers in this map

  1. Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis · Herbert Tilg · 2010 · 2556 citations · Cited by this paper
  2. Development and validation of a risk models for gout in patients with diabetic kidney disease · 2026 · Related
  3. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025 · Nuha A. ElSayed · 2024 · 1318 citations · Cited by this paper
  4. Association between HbA1c and red cell distribution width-standard deviation in newly diagnosed, treatment-naïve type 2 diabetes mellitus: a retrospective cross-sectional study · 2026 · Related
  5. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis · Thomas Karlas · 2016 · 1283 citations · Cited by this paper
  6. B vitamins and metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review of observational studies · 2026 · Related
  7. Role of Insulin Resistance in Human Disease (Syndrome X): An Expanded Definition · Gerald M. Reaven · 1993 · 883 citations · Cited by this paper
  8. Circulating spexin levels in women with PCOS (PMOS): relationships with phoenixin, BMI and perceived stress · 2026 · Related
  9. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study · Philip Noel Newsome · 2020 · 800 citations · Cited by this paper
  10. Comparison of demographic, clinical and follow-up data of patients with micromegaly and acromegaly: a retrospective analysis from a single tertiary center · 2026 · Related
  11. Current status and future trends of the global burden of MASLD · Lei Miao · 2024 · 754 citations · Cited by this paper
  12. Total parathyroidectomy versus total parathyroidectomy with autotransplantation for refractory secondary hyperparathyroidism: short-term biochemical outcomes and postoperative calcium supplementation burden · 2026 · Related
  13. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis · Jingxuan Quek · 2022 · 744 citations · Cited by this paper
  14. Association of creatinine to body weight ratio with glycemic progression and remission in Chinese adults with prediabetes: a large-scale retrospective cohort study · 2026 · Related
  15. Epidemiological Features of NAFLD From 1999 to 2018 in China · Jianghua Zhou · 2020 · 710 citations · Cited by this paper
  16. Factors associated with poor glycaemic control among adults with type 2 diabetes mellitus in Albania: a cross-sectional study · 2026 · Related
  17. Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association · P. Barton Duell · 2022 · 700 citations · Cited by this paper
  18. Real-world management of hypoparathyroidism: the impact of endocrinology specialist follow-up on biochemical and clinical outcomes - a retrospective cohort study · 2026 · Related
  19. Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease · Reenam S. Khan · 2018 · 549 citations · Cited by this paper
  20. Predictive models of adverse outcomes of overweight or obesity: a nationwide cohort validation · 2026 · Related
  21. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis · Ferenc Emil Mózes · 2021 · 520 citations · Cited by this paper
  22. Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease · Vian Azzu · 2020 · 379 citations · Cited by this paper
  23. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver · Paola Dongiovanni · 2017 · 375 citations · Cited by this paper
  24. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk · Emir M. Muzurović · 2021 · 357 citations · Cited by this paper
  25. Integrative metabolism in MASLD and MASH: Pathophysiology and emerging mechanisms · Gregory R. Steinberg · 2025 · 218 citations · Cited by this paper
  26. Are there outcome differences between NAFLD and metabolic‐associated fatty liver disease? · Zobair M. Younossi · 2022 · 183 citations · Cited by this paper
  27. The independent predictors of non‐alcoholic steatohepatitis and its individual histological features. · Stefano Ballestri · 2016 · 159 citations · Cited by this paper
  28. AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis · Hongjiao Xu · 2020 · 149 citations · Cited by this paper
  29. The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis · Preethi Chandrasekaran · 2024 · 83 citations · Cited by this paper
  30. Lipocalin‐2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high‐fat diet–fed Ob/Ob mice · Kyung Eun Kim · 2022 · 78 citations · Cited by this paper
  31. Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications · Xuan Trong Truong · 2025 · 75 citations · Cited by this paper
  32. Inflammation‐Responsive Cell Membrane‐Camouflaged Nanoparticles against Liver Fibrosis via Regulating Endoplasmic Reticulum Stress and Oxidative Stress · Yang Bai · 2024 · 66 citations · Cited by this paper
  33. The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients · Benjamin Rivière · 2022 · 62 citations · Cited by this paper
  34. Deciphering the molecular pathways of saroglitazar: A dual PPAR α/γ agonist for managing metabolic NAFLD · Devaraj Ezhilarasan · 2024 · 53 citations · Cited by this paper
  35. Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study · Sergio Fresneda · 2022 · 49 citations · Cited by this paper
  36. Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis · Jinwang Li · 2021 · 43 citations · Cited by this paper
  37. The adiponectin-PPARγ axis in hepatic stellate cells regulates liver fibrosis · Shangang Zhao · 2025 · 27 citations · Cited by this paper
  38. Differences in HDL-Bound Apolipoproteins in Patients With Advanced Liver Fibrosis Due to Nonalcoholic Fatty Liver Disease · Fernando Bril · 2022 · 20 citations · Cited by this paper
  39. High-Density Lipoprotein in Metabolic Disorders and Beyond: An Exciting New World Full of Challenges and Opportunities · Evangelia Zvintzou · 2023 · 18 citations · Cited by this paper

Source: OpenAlex (CC0)